Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-099652
Filing Date
2025-10-15
Accepted
2025-10-15 12:00:25
Documents
1
Period of Report
2025-10-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2528208-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2528208-4_4seq1.xml 4 3898
  Complete submission text file 0001104659-25-099652.txt   5457
Mailing Address C/O ASPREVA PHARMACEUTICALS CORPORATION 1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8
Business Address
Glickman Richard M (Reporting) CIK: 0001352637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 251394037

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER British Columbia, Canada
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER British Columbia, Canada (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)